Rubric Capital Management LP

Holdings History for Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Symbol: OVID on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 478,533 shares
Security Ownership %: 0.67%

Shares, Excluding Options vs Price

Value, Excluding Options

Rubric Capital Management LP ownership in Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID)

09 Jul 2025 - Rubric Capital Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 478,533 shares of Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID). This represents 0.67% ownership of the company. This is the first filing by Rubric Capital Management LP disclosing ownership of Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Rubric Capital Management LP	0.67%		$153,131	478,533			$0.32	13G/A	30 Jun 2025	09 Jul 2025, 16:08

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-478,533	-100%	$1.59	Q3 2025
30 Jun 2025	0%	-0.03%	$157,868	478,533	-4,837,436	-91%	$0.33	Q2 2025
31 Mar 2025	0.03%	0%	$1,658,051	5,315,969	0		$0.31	Q1 2025
31 Dec 2024	0.09%	0%	$4,963,520	5,315,969	0		$0.93	Q4 2024
30 Sep 2024	0.1%	0%	$6,272,843	5,315,969	0		$1.18	Q3 2024
30 Jun 2024	0.11%	0%	$4,089,043	5,315,969	0		$0.77	Q2 2024
31 Mar 2024	0.48%	0%	$16,213,705	5,315,969	0		$3.05	Q1 2024
31 Dec 2023	0.64%	-0.02%	$17,117,420	5,315,969	-129,941	-2.4%	$3.22	Q4 2023
30 Sep 2023	0.88%	0%	$20,912,294	5,445,910	0		$3.84	Q3 2023
30 Jun 2023	0.76%	-0.22%	$17,862,585	5,445,910	-1,555,214	-22%	$3.28	Q2 2023
31 Mar 2023	0.72%	+0.02%	$18,062,900	7,001,124	+173,059	+2.5%	$2.58	Q1 2023
31 Dec 2022	0.56%	+0.19%	$12,700,201	6,828,065	+2,311,765	+51%	$1.86	Q4 2022
30 Sep 2022	0.42%	+0.15%	$8,310,000	4,516,300	+1,633,594	+57%	$1.84	Q3 2022
30 Jun 2022	0.33%	+0.33%	$6,198,000	2,882,706	+2,882,706	NEW	$2.15	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.